This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Explore ways to reinforce good budgeting habits and build lasting momentum through tracking, rewards, and simple routines.
12,059 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Small-cap growth ETFs can be a powerful part of a diversified portfolio. This article compares ISCG and SLYG on costs...
When crude stays strong, oil stocks could reap billion in potential windfall earnings. This guide breaks down who ben...
When a high profile government move hits a new domain in the headlines, markets pay attention. This piece breaks down...
In a market rotating away from fast-growing tech, three dividend aristocrat stocks that have raised payouts for decad...
Executives gathered at the Fortune CEO Initiative dinner to debate debt risks, global diplomacy, and the role of busi...
Rocket Lab and AST SpaceMobile pursue different spacefrontiers, from reliable launches to space-based connectivity. T...
American Express has fallen notably in 2026, prompting questions about whether the drop makes it a bargain. This arti...
With a funding deadlock gripping the federal government, Trump’s border czar says ICE could be deployed to airport sc...
Figma stock has fallen in 2026 as AI-powered competitors gain ground. This guide breaks down whether the decline crea...
The U.S. Department of Housing and Urban Development has opened a Fair Housing Act investigation into Washington stat...
Insmed disclosed that Japan now hosts more MAC lung disease patients than the United States, a development that could...